Genomic Biomarkers for Pharmaceutical Development: Chapter 7. Translating Biomarker Discovery into Companion Diagnostics through Validation and Regulatory Consideration

Genomic Biomarkers for Pharmaceutical Development: Chapter 7. Translating Biomarker Discovery into Companion Diagnostics through Validation and Regulatory Consideration
ISBN-10
0128063564
ISBN-13
9780128063569
Series
Genomic Biomarkers for Pharmaceutical Development
Category
Medical
Pages
208
Language
English
Published
2013-07-16
Publisher
Elsevier Inc. Chapters
Authors
Philip Brohawn, Bahija Jallal, Brandon W. Higgs

Description

This chapter presents the processes required for the translation of a biomarker discovery from the research laboratory into a validated diagnostic for clinical application. To fully investigate the topic of assay validation, a brief review of the current regulatory guidance will be discussed, and thereafter this is used as the framework for topics surrounding assay validation. The time-sensitive stages in the assay development process and agreement with clinical development timelines are critical to delivering a viable clinic-ready assay. Methods to best maneuver this are presented to help emphasize the necessary level of validation for use of an assay in a clinical setting. Each pertinent stage is then described, and key focus areas are highlighted. For certain stages of the development process, such as cut-point determination, multiple vs. single analyte, classifier training/testing, and precision determination, various statistical arguments are presented to illustrate common misconceptions or potential pitfalls.

Similar books